Catalyst Wire Dossier Catalyst Wire Dossier

ZGN-433

· Zafgen, Inc.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for ZGN-433, covering 2011-12-30 to 2012-01-11. Get the full timeline:

Most recent: Clinical Trial Update: Safety, Tolerability and Pharmacokinetics of Multiple Doses of ZGN-433 in Obese Female Volunteers [Phase 1]

See pricing